Cart
sales@molnova.com
Fudosteine
CAS No. 13189-98-5
Fudosteine( SS320A )
Catalog No. M11291 CAS No. 13189-98-5
Fudosteine is a novel mucoactive agent and a MUC5AC mucin hypersecretion inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 45 | In Stock |
|
| 50MG | 59 | In Stock |
|
| 100MG | 105 | In Stock |
|
| 200MG | 156 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFudosteine
-
NoteResearch use only, not for human use.
-
Brief DescriptionFudosteine is a novel mucoactive agent and a MUC5AC mucin hypersecretion inhibitor.
-
DescriptionFudosteine is a novel mucoactive agent and a MUC5AC mucin hypersecretion inhibitor. (In Vitro):Fudosteine (50, 100, 200 mg/kg) decreases the LPS-induced p-ERK1/2 and p-p38 MAPK levels in the rat lungs. The TNF-α-induced increase in MUC5AC mRNA expression is inhibited by pretreatment with 1 mM Fudosteine.
-
In VitroFudosteine (50, 100, 200 mg/kg) decreases the LPS-induced p-ERK1/2 and p-p38 MAPK levels in the rat lungs. The TNF-α-induced increase in MUC5AC mRNA expression is inhibited by pretreatment with 1 mM Fudosteine.
-
In Vivo——
-
SynonymsSS320A
-
PathwayOthers
-
TargetOther Targets
-
RecptorMUC5AC mucin
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number13189-98-5
-
Formula Weight179.23
-
Molecular FormulaC6H13NO3S
-
Purity>98% (HPLC)
-
SolubilityWater: 36 mg/mL (200.84 mM)
-
SMILESN[C@@H](CSCCCO)C(O)=O
-
Chemical NameS-(3-hydroxypropyl)-L-cysteine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rhee CK, et al. Eur Respir J. 2008 Nov;32(5):1195-202.
molnova catalog
related products
-
Cyclo(Ile-Leu)
Cyclo(Ile-Leu) shows cytotoxic activity in vitro.
-
CTx0294885
CTX-0294885 is a a novel bisanilino pyrimidine; exhibits inhibitory activity against a broad range of kinases in vitro.
-
(S/R)-Orteronel
TAK-700 (Orteronel) is a potent and highly selective human 17, 20-lyase inhibitor with IC50 of 38 nM, exhibits >1000-fold selectivity over other CYPs (e.g. 11-hydroxylase and CYP3A4). Phase 3.
